Axsome Therapeutics, Inc. (AXSM)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 65.72 |
| Open | 65.50 |
| Bid | 67.87 x 100 |
| Ask | 67.99 x 200 |
| Day's Range | 65.50 - 68.14 |
| 52 Week Range | 55.02 - 98.40 |
| Volume | |
| Avg. Volume | 734,938 |
| Market Cap | 3.217B |
| Beta (5Y Monthly) | 1.10 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Axsome (AXSM) Begins Solriamfetol Binge Eating Phase III Study
Axsome's (AXSM) phase III ENGAGE study is set to evaluate the efficacy and safety of solriamfetol for the treatment of binge eating disorder in adults.
- GuruFocus.com
Insider Sell: COO Mark Jacobson Sells 24,662 Shares of Axsome Therapeutics Inc (AXSM)
Axsome Therapeutics Inc (NASDAQ:AXSM), a biopharmaceutical company focused on developing novel therapies for the management of central nervous system (CNS) disorders, has reported an insider sell according to a recent SEC filing.
- Insider Monkey
30 Countries with the Lowest Depression Rates
In this article, we will be taking a look at the 30 countries with the lowest depression rates. If you do not want to learn about the global depression treatment market, head straight to the 5 Countries with the Lowest Depression Rates. In countries with the lowest depression rates, individuals experience lower prevalence rates of […]
© 2024 Yahoo. All rights reserved.